Navigation Links
UCSD research reveals mechanism involved with type of fatal epilepsy

Researchers at University of California, San Diego (UCSD) have found that Lafora disease, an inherited form of epilepsy that results in death by the age of 30, can be caused by mutations in a gene that regulates the concentration of the protein laforin. These findings are reported in the current issue of Proceedings of the National Academy of Sciences (PNAS).

Lafora disease is characterized by normal development for the first decade of life, followed by an initial seizure in the second decade, progressively worsening seizures, early dementia, and death within 10 years of onset. Medications can ease the severity of initial symptoms, but there is no long-term treatment or cure for the disease.

A puzzling aspect of the disease is the accumulation of starch-/glycogen-like granules in most tissues of Lafora disease patients. Thus, researchers have long thought that a defect in glycogen metabolism is intimately linked to the disease. Recessive mutations in two genes have been shown to cause Lafora disease. The genes encode the proteins laforin and malin, but the molecular mechanism defining how loss of laforin or malin causes Lafora disease has remained unclear.

Jack E. Dixon, Ph.D., UCSD dean of scientific affairs and professor of pharmacology, and colleagues at UCSD investigated the role of malin in Lafora disease and found that malin physically interacts with laforin and regulates laforin's concentration by marking it for degradation. Their results show that approximately 40 percent of patients with Lafora disease have mutations in malin that render it unable to mark laforin for degradation. This increase in laforin may lead to Lafora disease through aberrant glycogen metabolism.

This work establishes a few testable models as to the molecular mechanism of the disease. Dixon and colleagues are currently designing experiments to test these models with the hope of gaining the necessary insights to develop potential therapies for Lafora disea
'"/>

Source:University of California - San Diego


Page: 1 2

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. U of M researcher examines newly emerging deadly disease
3. NYU researchers simulate molecular biological clock
4. First atlas of key brain genes could speed research on cancer, neurological diseases
5. New research questions basic tenet of neuron function
6. Vital step in cellular migration described by UCSD medical researchers
7. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
8. UCSD researchers maintain stem cells without contaminated animal feeder layers
9. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
10. New protein discovered by Hebrew University researchers
11. First real-time view of developing neurons reveals surprises, say Stanford researchers

Post Your Comments:
(Date:11/20/2009)...Mass., November 19, 2009 The estimated 4.6 millio... at risk of developing respiratory symptoms due to...uestionnaire study undertaken earlier this year by...ol of Veterinary Medicine. , The studywhich poll...d that 50 percent of individuals working in barns ...
(Date:11/20/2009)...s available in German . , In the current on...on , Dr. Stefanie Eyerich and Dr. Kilian Eyerich t...e London and Istituto Dermopatico dell,Immacolata ...t represents a milestone on the way to developing ...es such as psoriasis and allergic reactions and po...
(Date:11/20/2009)... In a new study, researchers report that a class ... a helpful, or harmful, effect on the heart, depen...hich appears in the journal Circulation Research ...pha- and beta-receptors on the heart muscle offer ...that target only the beta-receptors can actually u...
Breaking Biology News(10 mins):Barn personnel experience higher-than-average rates of respiratory symptoms 2Discovery of new type of immune cells regulating inflammation in chronic diseases 2Carvedilol shown to have unique characteristics among beta blockers 2New data from 10 year global flea monitoring program confirms imidacloprid remains highly effective 54458 1New data from 10 year global flea monitoring program confirms imidacloprid remains highly effective 54458 2Protein plays unexpected role protecting chromosome tips 54456 1Protein plays unexpected role protecting chromosome tips 54456 2Protein plays unexpected role protecting chromosome tips 54456 3Canadian scientists identify gene that makes water striders glide across water 9567 1
... Earth Institute at Columbia University have disco... Asian elephants in India is actually two genetica...ch appear in the current issue of the journal Anim...ons in conservation plans for the endangered eleph... , Prithiviraj Fernando, a post-doctoral researche...
...ares disability from acute stroke may be delivered...standard ?a potential advance needed to benefit mo... of South Florida found that human umbilical cord ...g a stroke greatly curbed the brain,s inflammatory...ulting in greatly improved recovery. The rats, inf...
...search project is coordinated from FinlandIn sprin...ork was establishedto investigate the causes and i... as from the social point of view. This EU-finance... sociological effects of sleep restriction" will l...Porkka-Heiskanen (Stenberg) MD, PhD, at theUnivers...
Other Biology News:Genetic analysis of Asian elephants in India reveals some surprises 2Cord blood cells may widen treatment window for stroke 2Do the Europeans turn ill sitting up so late? 2
(Date:11/19/2009)... , , ,, BETHESDA, Md., Nov. 19 /P...aq: SPEX ), an innovator in biotechnology for dia...ulatory consulting services to food, supplement, b...ed today it closed the previously reported $6.3 mi... investors of 2,760,870 shares of its common stock...
(Date:11/19/2009)... , , MALVERN, Pa. and WALTHAM, Mass., ...s (AMR) and Decision Resources find that the leadi...eumonia in Europe is broad-spectrum activity again...to the variety of organisms that can cause nosocom... that they look primarily for agents that provide ...
(Date:11/19/2009)... , Top LASIK surgeons and...s listed at Trusted LASIK Surgeons made brought th...opments in vision correction surgery, cataract sur... concluded American Academy of Ophthalmology (AAO)...Richard Lindstrom, Dr. Shachar Tauber, Dr. David H...
(Date:11/19/2009)... , , VIENNA, Austria, November 19 ...r,s vaccine program on one product candidate at an...ine candidate AD02 is planned to enter into,Phase ...the company,immediately follows the completion of ...02. The company based its fast decision on the fir...
Breaking Biology Technology:Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...sionals and Addressing the Issues ..., April 4, 2008 Clinical laboratory,professionals...itiative to,raise international awareness of the r... health care and their vital contribution to impro... Are Vital(TM), sponsored by,Abbott (NYSE: ABT ),...
...8 at 8:30 a.m. EDT - Rec... sales increased 21.2% year-over-year to ... guidance: revenue of $360 million to $370 million... million, - Net beds served increased 21% year-ove... pharmacy operations center in Deerfield Beach, Fl...
...ASDAQ Stock Market, OAKLAND, Calif., April 3, 200...ion (WorldHeart or Corporation) announced,today th... fiscal year,ended December 31, 2007 contained a g...endent registered public accounting firm, Burr Pil...o comply with NASDAQ Marketplace Rule,4350(b)(1)(B...
Other Biology Technology:International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative 2International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) Initiative 3Chem Rx Corporation Reports Full Year 2007 Financial Results 2Chem Rx Corporation Reports Full Year 2007 Financial Results 3Chem Rx Corporation Reports Full Year 2007 Financial Results 4Chem Rx Corporation Reports Full Year 2007 Financial Results 5Chem Rx Corporation Reports Full Year 2007 Financial Results 6Chem Rx Corporation Reports Full Year 2007 Financial Results 7Chem Rx Corporation Reports Full Year 2007 Financial Results 8Chem Rx Corporation Reports Full Year 2007 Financial Results 9Chem Rx Corporation Reports Full Year 2007 Financial Results 10Chem Rx Corporation Reports Full Year 2007 Financial Results 11Chem Rx Corporation Reports Full Year 2007 Financial Results 12Chem Rx Corporation Reports Full Year 2007 Financial Results 13Chem Rx Corporation Reports Full Year 2007 Financial Results 14Chem Rx Corporation Reports Full Year 2007 Financial Results 15WorldHeart 10-KSB Audit Report Includes 'Going Concern' Qualification 2
Rabbit Anti-Streptococcus Enterotoxin C Polyclonal Antibody, Unconjugated from Abcam
Cultured Human Visceral (omental) preadipocytes from Zen-Bio, Inc.
Mouse Anti-Human Flavocytochrome b Monoclonal Antibody, FITC Conjugated, Clone 7D5 from MBL International
UltraClean Microbial DNA Isolation Kit from Mo Bio Laboratories, Inc.
Biology Products: